Log inSign up
Journal of Clinical Oncology
12.6K posts
user avatar
Journal of Clinical Oncology
@JCO_ASCO
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, @JCOPO_ASCO, @JCOOA_ASCO.
ascopubs.org/jco
Joined March 2014
1,135
Following
56.1K
Followers
  • Pinned
    user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Dec 13, 2023
    Celebrating 40 years of pioneering oncology research with @ASCO's Journal of Clinical Oncology! We're thrilled to share this milestone in our history. Look forward to the reveal of our most-cited publication on 12/15. Discover the top-cited articles: [ascopubs.org/jco/40th-anniv…]
    00:00
    28K
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Oct 11, 2022
    🙌 Enfortumab vedotin + pembro as 1st-line tx for metastatic #UrothelialCancer yields response rate of 73.3%, duration of response 25.6 mo, overall survival 26.1 mo. 👉 fal.cn/3sEjU #JCO #blcsm #kcsm #gucsm @DrRosenbergMSK
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Jun 30, 2021
    ‼️ #JCO's 2020 impact factor increased to 44.544, which is the highest among oncology publications and in the top 1️⃣% of all journals. fal.cn/3gsVk
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Apr 3, 2022
    No more reformatting! Submit your manuscript format-free to @ASCO Journals with EZSubmit ✅ fal.cn/3nubO
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Nov 1, 2023
    ☢️🦴 In a multi-center RCT ⚖️ (n=78), radiation to high-risk asymptomatic bone metastases ⬇️ skeletal-related events and prolonged overall survival in metastatic solid tumors: brnw.ch/21wE43a #radonc @ErinGillespieMD
    60K
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Oct 17, 2022
    ‼️ @ASCO Guideline just published: Treatment of Metastatic Colorectal Cancer Read in #JCO ➡️ fal.cn/3sOlo #crcsm #mCRC
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    May 8, 2020
    #ASCOEdBook 📖 Editor in Chief @drdonsdizon invites you to access 🆕 2020 Ed Book articles for free at asco.org/edbook
    00:00
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Apr 10, 2023
    🍴 Olanzapine improved appetite and led to weight gain among patients with cancer undergoing #chemotherapy. #JCO #pallonc #supponc ➡️ fal.cn/3xhpC
    27K
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Mar 5, 2021
    Primary tumor resection followed by chemotherapy in patients with metastatic colorectal cancer doesn't improve survival over chemotherapy alone fal.cn/3dOjs @JCOG_official #crcsm #JCO
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Apr 26, 2020
    Breast cancer: 45 years of research & progress fal.cn/37KOd #bcsm #JCO
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Sep 18, 2019
    Patients with mismatch repair-deficient stomach cancer may not benefit from perioperative or adjuvant chemotherapy – results from 4 international randomised trials bit.ly/2mleOy7 #stcsm @CRUKCamAero
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Jun 20, 2019
    JCO 2018 Impact Factor has risen to 28.245, the highest in the history of the Journal bit.ly/2UKyfjh
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Jun 28, 2022
    We’re pleased to announce our new impact factor of 50.717‼️ Thank you to our authors and reviewers! #JCO #OncTwitter
  • user avatar
    Journal of Clinical Oncology
    @JCO_ASCO
    Dec 15, 2023
    Celebrating JCO's 40th: Congrats to the #1 most cited #JCO article of the past 40 years! 'Gemcitabine For Advanced Pancreas Cancer' by @BurrisSkip et al. (1997). Read the Flashback Foreword by @EileenMOReilly, Andrew L. Ko, MD, @DrJFriedberg 👉 brnw.ch/21wFmYc #OncTwitter
    120K

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up